The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: risperdal consta     Quarter: 2016Q3

Total Records: 310     Number of Pages: 16

DRUGNAME PT EventCount
RISPERDAL CONSTA Ejection fraction decreased 2
RISPERDAL CONSTA Electrocardiogram PR prolongation 2
RISPERDAL CONSTA Exercise tolerance decreased 2
RISPERDAL CONSTA Feeling of despair 2
RISPERDAL CONSTA Femur fracture 2
RISPERDAL CONSTA Gait disturbance 2
RISPERDAL CONSTA Gastrointestinal necrosis 2
RISPERDAL CONSTA Globulins decreased 2
RISPERDAL CONSTA High density lipoprotein decreased 2
RISPERDAL CONSTA Homicide 2
RISPERDAL CONSTA Hyperphagia 2
RISPERDAL CONSTA Impaired healing 2
RISPERDAL CONSTA Impaired work ability 2
RISPERDAL CONSTA Inadequate diet 2
RISPERDAL CONSTA Incorrect route of drug administration 2
RISPERDAL CONSTA Injection site extravasation 2
RISPERDAL CONSTA Injury 2
RISPERDAL CONSTA Intestinal dilatation 2
RISPERDAL CONSTA Ischaemic cardiomyopathy 2
RISPERDAL CONSTA Left ventricular dysfunction 2

Total Records: 310     Number of Pages: 16